← Leaderboards
Peiying Yang
University Of Tx Md Anderson Can Ctr
$3,054,615
Attributed
$4,753,730
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $688.6K · FY2008–25$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,753,730 · 5
By mechanism
R01$3,805,486 · 2
P01$510,341 · 1
R21$429,903 · 1
R13$8,000 · 1
Top collaborators
- Diana S-L. Chow5 shared
- Chun Li5 shared
- Lorenzo Cohen1 shared
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Haoqiang Ying$2,821,763
- Terisa Davis$2,914,122
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsMonitorPharmaceutical PreparationsTumorPathway InteractionsLiquid ChromatographyCancer CellSuccessInhibitor/AntagonistMass Spectrum AnalysisSeriesMalignant Breast NeoplasmCelecoxibAnimal ModelInsightMutationResponseFutureDinoprostoneAdenocarcinomaDosePharmacodynamicsBiologicalChemotherapy
Grant awards (17)
Pre-IND Development of Polymeric Micelles with Dual Drug Payloads for HCC Therapy$627,482
R01 · FY2025 · CA
Pre-IND Development of Polymeric Micelles with Dual Drug Payloads for HCC Therapy$61,165
R01 · FY2025 · CA
Pre-IND Development of Polymeric Micelles with Dual Drug Payloads for HCC Therapy$596,109
R01 · FY2024 · CA
Pre-IND Development of Polymeric Micelles with Dual Drug Payloads for HCC Therapy$614,932
R01 · FY2023 · CA
Pre-IND Development of Polymeric Micelles with Dual Drug Payloads for HCC Therapy$642,984
R01 · FY2022 · CA
ANALYTICAL CORE$99,443
P01 · FY2016 · CA · contact PI
ANALYTICAL CORE$99,444
P01 · FY2015 · CA · contact PI
ANALYTICAL CORE$118,534
P01 · FY2014 · CA · contact PI
Personalized Integrative Oncology: Targeted Approaches for Optimal Outcomes$8,000
R13 · FY2014 · CA · contact PI
Chemopreventive effect of fish oil derived EPA in lung cancer$298,934
R01 · FY2013 · CA · contact PI
ANALYTICAL CORE$93,476
P01 · FY2013 · CA · contact PI
Chemopreventive effect of fish oil derived EPA in lung cancer$318,015
R01 · FY2012 · CA · contact PI
ANALYTICAL CORE$99,444
P01 · FY2012 · CA · contact PI
Chemopreventive effect of fish oil derived EPA in lung cancer$318,015
R01 · FY2011 · CA · contact PI
Chemopreventive effect of fish oil derived EPA in lung cancer$327,850
R01 · FY2010 · CA · contact PI
Sweet gum extract and late stage prostate cancer$227,508
R21 · FY2009 · AT · contact PI
Sweet gum extract and late stage prostate cancer$202,395
R21 · FY2008 · AT · contact PI